183 related articles for article (PubMed ID: 36525654)
1. Factors Related to Human Papillomavirus Positivity among Oral Cavity and Pharynx Cancers from Surveillance, Epidemiology and End Results (SEER) Program Data.
Jordan KH; Fisher JL; Stephens JA; Paskett ED
Cancer Epidemiol Biomarkers Prev; 2023 Mar; 32(3):452-462. PubMed ID: 36525654
[TBL] [Abstract][Full Text] [Related]
2. Distinct sociodemographic differences in incidence and survival rates for human papillomavirus (HPV)-like, non-HPV-like, and "other"-like oral cavity and pharynx cancers: An analysis of Surveillance, Epidemiology and End Results (SEER) Program data.
Jordan KH; Fisher JL; Paskett ED
Front Oncol; 2022; 12():980900. PubMed ID: 36072808
[TBL] [Abstract][Full Text] [Related]
3. Differences in incidence and survival of oral cavity and pharyngeal cancers between Germany and the United States depend on the HPV-association of the cancer site.
Jansen L; Buttmann-Schweiger N; Listl S; Ressing M; Holleczek B; Katalinic A; Luttmann S; Kraywinkel K; Brenner H;
Oral Oncol; 2018 Jan; 76():8-15. PubMed ID: 29290288
[TBL] [Abstract][Full Text] [Related]
4. Oropharyngeal cancer incidence trends: diminishing racial disparities.
Brown LM; Check DP; Devesa SS
Cancer Causes Control; 2011 May; 22(5):753-63. PubMed ID: 21380619
[TBL] [Abstract][Full Text] [Related]
5. Inaccuracies in oral cavity-pharynx cancer coded as the underlying cause of death on U.S. death certificates, and trends in mortality rates (1999-2010).
Polednak AP
Oral Oncol; 2014 Aug; 50(8):732-9. PubMed ID: 24862544
[TBL] [Abstract][Full Text] [Related]
6. The prognostic role of sex, race, and human papillomavirus in oropharyngeal and nonoropharyngeal head and neck squamous cell cancer.
Fakhry C; Westra WH; Wang SJ; van Zante A; Zhang Y; Rettig E; Yin LX; Ryan WR; Ha PK; Wentz A; Koch W; Richmon JD; Eisele DW; D'Souza G
Cancer; 2017 May; 123(9):1566-1575. PubMed ID: 28241096
[TBL] [Abstract][Full Text] [Related]
7. Incidence of oral cavity and pharyngeal cancers by anatomical sites in population-based registries in Puerto Rico and the United States of America.
Suárez E; González L; Díaz-Toro EC; Calo WA; Bermúdez F; Ortiz AP
P R Health Sci J; 2013 Dec; 32(4):175-81. PubMed ID: 24397214
[TBL] [Abstract][Full Text] [Related]
8. Incidence and Demographic Burden of HPV-Associated Oropharyngeal Head and Neck Cancers in the United States.
Mahal BA; Catalano PJ; Haddad RI; Hanna GJ; Kass JI; Schoenfeld JD; Tishler RB; Margalit DN
Cancer Epidemiol Biomarkers Prev; 2019 Oct; 28(10):1660-1667. PubMed ID: 31358520
[TBL] [Abstract][Full Text] [Related]
9. Burden of potentially human papillomavirus-associated cancers of the oropharynx and oral cavity in the US, 1998-2003.
Ryerson AB; Peters ES; Coughlin SS; Chen VW; Gillison ML; Reichman ME; Wu X; Chaturvedi AK; Kawaoka K
Cancer; 2008 Nov; 113(10 Suppl):2901-9. PubMed ID: 18980273
[TBL] [Abstract][Full Text] [Related]
10. Bidirectional association of anogenital and oral cavity/pharyngeal carcinomas in men.
Sikora AG; Morris LG; Sturgis EM
Arch Otolaryngol Head Neck Surg; 2009 Apr; 135(4):402-5. PubMed ID: 19380365
[TBL] [Abstract][Full Text] [Related]
11. Differences in Sociodemographic Correlates of Human Papillomavirus-Associated Cancer Survival in the United States.
Osazuwa-Peters N; Simpson MC; Rohde RL; Challapalli SD; Massa ST; Adjei Boakye E
Cancer Control; 2021; 28():10732748211041894. PubMed ID: 34696619
[TBL] [Abstract][Full Text] [Related]
12. Elevated risk of human papillomavirus-related second cancers in survivors of anal canal cancer.
Nelson RA; Lai LL
Cancer; 2017 Oct; 123(20):4013-4021. PubMed ID: 28608917
[TBL] [Abstract][Full Text] [Related]
13. Using Data on Tumor Grade in Cancer Registries to Enhance Surveillance of Oropharyngeal Cancers in Relation to the Human Papillomavirus Epidemic.
Polednak AP
J Registry Manag; 2016; 43(1):29-35. PubMed ID: 27195996
[TBL] [Abstract][Full Text] [Related]
14. Human papillomavirus-associated cancer incidence by disaggregated Asian American, Native Hawaiian, and other Pacific Islander ethnicity.
Shing JZ; Corbin J; Kreimer AR; Carvajal LJ; Taparra K; Shiels MS; Vo JB
JNCI Cancer Spectr; 2023 Mar; 7(2):. PubMed ID: 36790075
[TBL] [Abstract][Full Text] [Related]
15. Annual Report to the Nation on the Status of Cancer, 1975-2009, featuring the burden and trends in human papillomavirus(HPV)-associated cancers and HPV vaccination coverage levels.
Jemal A; Simard EP; Dorell C; Noone AM; Markowitz LE; Kohler B; Eheman C; Saraiya M; Bandi P; Saslow D; Cronin KA; Watson M; Schiffman M; Henley SJ; Schymura MJ; Anderson RN; Yankey D; Edwards BK
J Natl Cancer Inst; 2013 Feb; 105(3):175-201. PubMed ID: 23297039
[TBL] [Abstract][Full Text] [Related]
16. Head and neck second primary cancer rates in the human papillomavirus era: A population-based analysis.
Diaz DA; Reis IM; Weed DT; Elsayyad N; Samuels M; Abramowitz MC
Head Neck; 2016 Apr; 38 Suppl 1():E873-83. PubMed ID: 25966421
[TBL] [Abstract][Full Text] [Related]
17. Association of Human Papillomavirus Status With Suicide Risk Among Patients With Head and Neck Cancer.
Chakoma T; Moon PK; Osazuwa-Peters OL; Megwalu UC; Osazuwa-Peters N
JAMA Otolaryngol Head Neck Surg; 2023 Apr; 149(4):291-299. PubMed ID: 36795392
[TBL] [Abstract][Full Text] [Related]
18. Understanding personal risk of oropharyngeal cancer: risk-groups for oncogenic oral HPV infection and oropharyngeal cancer.
D'Souza G; McNeel TS; Fakhry C
Ann Oncol; 2017 Dec; 28(12):3065-3069. PubMed ID: 29059337
[TBL] [Abstract][Full Text] [Related]
19. Oral cavity and oropharyngeal cancer incidence trends and disparities in the United States: 2000-2010.
Weatherspoon DJ; Chattopadhyay A; Boroumand S; Garcia I
Cancer Epidemiol; 2015 Aug; 39(4):497-504. PubMed ID: 25976107
[TBL] [Abstract][Full Text] [Related]
20. The incidence of oropharyngeal cancer and rate of human papillomavirus vaccination coverage in Florida, 2011 through 2015.
Khan N; Tomar SL
J Am Dent Assoc; 2020 Jan; 151(1):51-58. PubMed ID: 31902400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
